AIM ImmunoTech, Inc. (AIM)

1.36 -0.09 (-6.21%) USD  |  NYAM  |  Dec 12, 16:00
1.36 0.00 (0.00%) After-Hours: 20:00
More

AIM ImmunoTech Research and Development Expense (Annual): 6.149M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for AIM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Agenus, Inc. 155.53M
Curis, Inc. 38.56M
Halozyme Therapeutics, Inc. 79.05M
Protalix Biotherapeutics, Inc. 12.97M
Armata Pharmaceuticals, Inc. 34.43M